NDC 0280-0029 - BAYER 500 mg
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0280-0029
- Package NDCs from labels
- 0280-0029-02, 0280-0029-10, 0280-0029-01
- Manufacturer
- Bayer HealthCare LLC
- Effective date
- 2025-01-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| BAYER 500 mg - Bayer HealthCare LLC | Bayer HealthCare LLC | 2025-01-17 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0280-0029-01 | BAYER 500 mg | 100 in 1 CARTON | POWDER | 100 | 5 | |
| 0280-0029-01 | BAYER 500 mg | 1 in 1 PACKET | POWDER | 1 | 5 | |
| 0280-0029-02 | BAYER 500 mg | 1 in 1 PACKET | POWDER | 1 | 5 | |
| 0280-0029-02 | BAYER 500 mg | 2 in 1 CARTON | POWDER | 2 | 5 | |
| 0280-0029-10 | BAYER 500 mg | 10 in 1 CARTON | POWDER | 10 | 5 | |
| 0280-0029-10 | BAYER 500 mg | 1 in 1 PACKET | POWDER | 1 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | BAYER 500 MG (ASPIRIN) POWDER [BAYER HEALTHCARE LLC] | 1 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | BAYER 500 MG (ASPIRIN) POWDER [BAYER HEALTHCARE LLC] | 1 | |
| ACESULFAME POTASSIUM | INACTIVE INGREDIENT | 23OV73Q5G9 | BAYER 500 MG (ASPIRIN) POWDER [BAYER HEALTHCARE LLC] | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | BAYER 500 MG (ASPIRIN) POWDER [BAYER HEALTHCARE LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.